Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Formato: article
Lenguaje:EN
Publicado: Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2021
Materias:
|contrast-enhanced ultrasound|hepatocellular carcinoma|transarterial radioembolization|transarterial chemoembolization|treatment response
Medical technology
R855-855.5
Medicine
R
Acceso en línea:https://doaj.org/article/1eb063ed83bc4dde8db81afc1a651394
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares